Call of the wild: Singapore businesses still keen on emerging markets
Overseas trips, trade fairs set to resume despite pandemic hiatus, global uncertainties
Annabeth Leow
IT WAS late 2019, and Singapore biotech startup Stratificare was all set to begin clinical studies in partnership with experts in Mexico, for a test that might prove able to predict severe cases of dengue.
The tie-up arose from Stratificare's participation in a business delegation accompanying Prime Minister Lee Hsien Loong on his official visit to that country.
But the novel coronavirus hit – and that made it “very difficult for us to run any clinical study there”, Stratificare chief executive Anthony Chua told The Business Times.
TRENDING NOW
Shanda co-founder sells Tanglin Hill bungalow for S$76 million
Nearly half of Apac’s wealthy expect market crash or correction, plan to rotate to cash: study
Yeo’s, Tiger Beer and now Gardenia – flight of food manufacturing from Singapore might be just as planned
Jumbo Seafood to close flagship East Coast Seafood Centre outlet on Sep 30